Holen Sie sich die Stockscreener-App
18.81
0.11%
-0.02
Handel nachbörslich:
18.85
0.04
+0.21%
Schlusskurs vom Vortag:
$18.83
Offen:
$18.72
24-Stunden-Volumen:
121.34K
Relative Volume:
0.56
Marktkapitalisierung:
$286.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.47M
KGV:
-19.00
EPS:
-0.99
Netto-Cashflow:
$-52.33M
1W Leistung:
-12.65%
1M Leistung:
-13.72%
6M Leistung:
-35.93%
1J Leistung:
+168.71%
1-Tages-Spanne:
$18.56
$19.35
1-Wochen-Bereich:
$17.37
$23.32
52-Wochen-Spanne:
$4.00
$31.01
Jasper Therapeutics Inc Stock (JSPR) Company Profile
Firmenname
Jasper Therapeutics Inc
Sektor
Branche
Telefon
(650) 549-1400
Adresse
2200 BRIDGE PKWY SUITE #102, REDWOOD CITY
Jasper Therapeutics Inc Stock (JSPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-11 | Eingeleitet | CapitalOne | Overweight |
| 2022-02-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Eingeleitet | Credit Suisse | Outperform |
| 2021-10-21 | Eingeleitet | William Blair | Outperform |
| 2021-10-20 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-10-13 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Jasper Therapeutics Inc Aktie (JSPR) Neueste Nachrichten
Jasper Therapeutics' SWOT analysis: briquilimab's potential in mast cell diseases - Investing.com
Fanconi Anemia Market Expected to Experience Major Growth - openPR
Fanconi Anemia Market Expected to Experience Major Growth by 2034, According to DelveInsight | Novartis, Foresee Pharma, Rocket Pharma, Jasper Therapeutics - The Globe and Mail
Jasper Therapeutics (NASDAQ:JSPR) Earns "Market Outperform" Rating from JMP Securities - MarketBeat
Jasper Therapeutics Inc [JSPR] Shares Jump Approximately 156.76% Over the Year - Knox Daily
Insider Selling: Kabot Brian, Momentus Inc [MNTS] Director divested 400 shares - Knox Daily
Jasper Therapeutics Inc (JSPR) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Jasper Therapeutics Inc’s Market Journey: Closing Weak at 18.23, Down -16.34 - The Dwinnex
Jasper concerns driven by Celldex data ‘overdone,’ says Stifel - TipRanks
Front Street Capital Management Inc. Sells 4,073 Shares of Kimball Electronics, Inc. (NASDAQ:KE) - Defense World
First Light Asset Management LLC Sells 482 Shares of Simulations Plus, Inc. (NASDAQ:SLP) - Defense World
Booz Allen Hamilton Holding Co. (NYSE:BAH) Shares Acquired by Providence Capital Advisors LLC - Defense World
Needham maintains Buy rating on Jamf shares with no price target change - Investing.com India
When (JSPR) Moves Investors should Listen - Stock Traders Daily
Y-mAbs Therapeutics (NASDAQ:YMAB) Trading Down 4.7% - Defense World
Jasper Therapeutics, Inc. (NASDAQ:JSPR) Shares Sold by Ally Bridge Group NY LLC - Defense World
Jasper is open to visitors again — but what can tourists expect? - CBC.ca
Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Massachusetts Financial Services Co. MA Decreases Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - Defense World
Ally Bridge Group NY LLC Trims Stock Holdings in Jasper Therapeutics, Inc. (NASDAQ:JSPR) - MarketBeat
Quest Partners LLC Has $40,000 Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - Defense World
"Let’s go crazy in front of the best fans": Kentucky's Jasper Johnson tries to lure Caleb Wilson and Acaden Lewis to the Wildcats - Sportskeeda
Jasper Johnson pitches Kentucky to Caleb Wilson and Acaden Lewis - KSR
Short Interest in Jasper Therapeutics, Inc. (NASDAQ:JSPR) Increases By 8.7% - Defense World
Jasper Therapeutics, Inc. (NASDAQ:JSPR) Sees Large Increase in Short Interest - MarketBeat
Sources Say goes LIVE with Kentucky commit Jasper Johnson! - KSR
Aquestive Therapeutics Inc’s latest rating changes from various analysts - Knox Daily
Jewett-Cameron Adds Three New Supply Partners for its Products - NRToday.com
Jasper Johnson had a month of being "torn" before committing to Kentucky - A Sea Of Blue
Jasper lifting state of local emergency, receives 13 EOIs for interim housing - Hamilton Spectator
Quest Partners LLC Purchases 982 Shares of Axon Enterprise, Inc. (NASDAQ:AXON) - Defense World
Financial Analysis: ADMA Biologics (NASDAQ:ADMA) vs. Jasper Therapeutics (NASDAQ:JSPR) - Defense World
Jasper state of local emergency ending; visitors asked to be respectful - CTV News Edmonton
Jasper ending state of emergency as focus shifts to long-term recovery from wildfire - Winnipeg Free Press
Jasper Therapeutics COO sells shares worth over $19,000 By Investing.com - Investing.com Australia
(JSPR) Trading Report - Stock Traders Daily
Jasper Therapeutics COO sells shares worth over $19,000 - Investing.com
Jasper Therapeutics, Inc. (NASDAQ:JSPR) COO Sells $19,107.00 in Stock - MarketBeat
Jasper Therapeutics gets Canada nod for asthma study - Investing.com
Jasper Therapeutics Announces Health Canada Clearance of - GlobeNewswire
Jasper Therapeutics Announces Health Canada Clearance of Clinical Trial Application for Phase 1b/2a Study of Briquilimab in Asthma - StockTitan
Jasper Therapeutics (NASDAQ:JSPR) Receives Overweight Rating from Cantor Fitzgerald - Defense World
Jasper Therapeutics (NASDAQ:JSPR) Receives New Coverage from Analysts at JMP Securities - Defense World
Cantor Fitzgerald Reaffirms "Overweight" Rating for Jasper Therapeutics (NASDAQ:JSPR) - MarketBeat
Jasper Therapeutics stock set for growth with novel stem cell therapyJMP - Investing.com Canada
JMP Securities Begins Coverage on Jasper Therapeutics (NASDAQ:JSPR) - MarketBeat
Jasper Therapeutics initiated with an Outperform at JMP Securities - TipRanks
Addiction Therapeutics Market Current Impact to Make Big Changes - La Funcion mx
Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences - GlobeNewswire
Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences - Yahoo Finance UK
Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences - Yahoo Finance
Finanzdaten der Jasper Therapeutics Inc-Aktie (JSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
4.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):